Xcelience Expands CTS Capabilities

Xcelience has expanded clinical trial supplies manufacturing and packaging capabilities with four new pieces of manufacturing equipment and an automated packaging line.

The company added a MG Futura (capsule-filling machine for powder and pellets), LCI Multi-granulator MG-55 (extruder), QJ-230T marumerizer (spheronizer), and wurster insert (bottom spray) to its existing Glatt GPCG-3 fluid bed processor. The new equipment allows for production, coating and encapsulation of MUDF delivery systems.

“The addition of the MG Futura improves production times, increases overall capacity and expands upon our existing capabilities for powders, pellets and powder micro-dosing for inhalation systems,” said Theodore Koontz, director of Operations.

In addition, Xcelience has added a fully-automated packaging line (including ink-jet coding) for primary bottling of tablets and capsules. The new packaging line enhances the speed at which batches are packaged, shortens timelines to clinical trials, and enhances our ability to package larger batches of drug product.